via NEWMEDIAWIRE -- CLS Holdings USA, Inc. (OTCQB: CLSH, CSE:
CLSH.CN) (“CLS” or the ''Company''), a diversified cannabis company
operating as Cannabis Life Sciences, is pleased to report its
consolidated financial results for the fourth quarter and fiscal
year ended May 31, 2019.
● Completed the acquisition
of Oasis Cannabis (“Oasis”) in Las Vegas, Nevada, a fully
integrated cannabis operation.
● Consolidated fourth quarter
and annual revenue of $2.9 million and $8.5 million,
respectively.
● Acquisition of
Massachusetts dispensary, In Good Health, anticipated to close in
Q1 of calendar 2020.
● Launch of the Company's
proprietary extraction and conversion processing facility expected
in Q1 of calendar 2020.
Chairman Note
“Since the acquisition of our Oasis Cannabis dispensary in June
2018, we have been incredibly focused on improving its operations,
which efforts we believe are starting to pay off,” commented Mr.
Jeff Binder, Chairman and CEO. “For fiscal 2019, we
achieved record annual revenue of $8.5 million, more than one third
of which stemmed from the fourth quarter. In addition to
the acquisition of Oasis, 2019 was full of successes, including
Oasis’ grand reopening, locking up the planned acquisition of In
Good Health, and the expansion of City Trees, our branded products
and bulk flower division. Significantly, we were awarded a
non-provisional, US utility patent for our leading-edge cannabidiol
extraction and conversion process. We are excited about
the potential competitive advantage and additional revenue streams
that this technology is expected to represent.”
Financial Highlights
● Q4 2019 consolidated
revenue of $2.9 million, an increase of $0.6 million or 23.5% over
Q3 2019.
● Fiscal year 2019 consolidated
revenue of $8.5 million, including $5.5 million from Oasis and $3.0
million from City Trees.
● As of May 31, 2019, total assets
were $46.5 million, including cash and cash equivalents of $10.5
million. Total debt was $18.5 million.
Operational Highlights
● In June 2018, CLS Holdings
completed the acquisition of Oasis, a fully integrated cannabis
operation located in Las Vegas, Nevada. In April 2019,
the Company celebrated Oasis’ grand reopening following a complete
redesign of the dispensary resulting in a modern facility which is
more inviting and vibrant and offers a superior customer
experience. Since reopening, Oasis has reported record
revenue, and revenue per square foot now exceeds
$420. As a result of Oasis’ success, the Company intends
to prototype the Oasis dispensary as its model and benchmark for
future dispensary renovations and openings.
● City Trees, the Company’s branded
products and bulk flower division, experienced significant growth
across the board. For fiscal year 2019, City Trees
reported record annual revenue of $3.0 million. City
Trees is available in more than 70% of dispensaries throughout
Nevada, which penetration is expected to increase as the Company
continues to augment its innovative product offerings.
● In January 2019, the Company
entered into an option agreement to acquire In Good
Health. In Good Health, a licensed medical dispensary
located in Brockton, Massachusetts, has been operational since
September 2015 and is the second of 38 licensed dispensaries in
Massachusetts, a market which legalized recreational retail sales
on November 20, 2018. Under the terms of the agreement,
the Company advanced $5.0 million to In Good Health and has been
working closely with its CEO, David Noble, to implement its
business plan in anticipation of closing. In June 2019,
In Good Health entered into a Host Community Agreement with the
Town of Sandwich for a second dispensary in
Massachusetts. Management expects to complete this
acquisition in January 2020, subject to receipt of
financing.
Corporate Highlights
● During fiscal year 2019, the
Company further solidified its management team with the additions
of (i) Andrew Glashow, President and Chief Operating Officer, who
has an abundance of experience in strategy, investment
banking, and finance and who was instrumental in the Oasis
acquisition and (ii) Gregg Carlson, Chief Financial Officer,
who brings to the Company more than 20 years of accounting and
finance-related expertise in gaming, lodging, real estate, retail,
and cannabis.
● In January 2019, the Company’s
common shares commenced trading on the Canadian Securities Exchange
under the ticker symbol “CLSH”.
● In February 2019, Canaccord
Genuity, one of the largest independent investment dealers in
Canada, initiated research coverage of the Company.
Chairman's Comments on Current Business and Future
Growth Strategy
"We are extremely pleased to share with you our fourth quarter
and fiscal year 2019 results. We experienced outstanding growth at
Oasis in both revenue and customers while successfully growing City
Trees into a mainstay cannabis brand available in more than 70% of
dispensaries in Nevada.
We are proud of these top line results and have several
initiatives in mind to further extend our brand and retail market
share. To this end, we plan to launch our proprietary
extraction and conversion process in early calendar
2020.
Once operational, the combined output at full capacity is
expected to be roughly 300,000 grams of finished oil per month
producing annualized revenue of roughly US$18 million at current
price levels. We plan to utilize this new vertical
component of our business to supply oil to our City Trees brand,
which will lower overall cost and allow us to expand our market
share in Nevada, as well as provide cannabidiol oil products to
other brands in Nevada via wholesale and white label programs.
Growth Initiatives at our Oasis Dispensary
Business
As mentioned earlier, we have greatly increased the average
daily customer count at our Oasis dispensary to just shy of 600
people per day over the past five months. In order to accommodate
this increased customer traffic, we are planning a third expansion
to our store, which will add an additional 20% of retail floor
space to the current footprint. In addition to added floor space,
we are adding 4 new checkout lines/registers, which will bring our
total to seven registers. These changes will allow us to handle
increased customer traffic and improve the customer experience by
lowering wait times to checkout during peak hours.
Initiatives to Grow our City Trees Brand of CBD and THC
Products
In terms of further building on the success of our City Trees
brand, we have much planned for the next 12 months. Already in over
70% of the dispensaries in Nevada, our goal will be to continue to
grow overall sales of the brand. One of the key initiatives we will
be launching in 2020 is a full re-branding of City Trees including
material imaging/packaging and marketing upgrades to make our City
Trees brand stand out.
Exclusive Distributor for CENTR Group CBD Infused
Beverages
We recently announced that CLS Holdings has been named as the
exclusive dispensary distributor for CENTR Brands Corps' full line
of CBD infused beverages. We were proud to be chosen among our many
competitors to represent their line of beverages and we feel this
is a win-win for both groups as CENTR now has access to a large
percentage of Nevada dispensaries that we currently do
business with via our City Trees brand.
Our "Customer First" Culture and Launch of Comprehensive
Delivery Service
Throughout our enterprise, we look at everything with a
"customer first" emphasis. If we see something that can improve our
customers’ experience or provide meaningful value, that is
something that we are interested in moving forward and
implementing. So in addition to adding floor space to the Oasis
dispensary to improve the customer experience, we have been working
on, and will be launching in early 2020 a comprehensive delivery
service to augment our Oasis retail dispensary. To make the
ordering process even easier for customers, we will be combining
this service with a custom designed smartphone app which will
streamline the customer ordering process even further. To get the
word out on our delivery program, we have planned a thorough
awareness campaign, which includes utilizing social media, website,
SEO and prominent billboards placed in key, high traffic Las Vegas
locations. (If you live in Las Vegas, or plan to visit us soon, you
will most likely see one of our billboards). In addition to the
high value we place on our loyal customer base, we place a high
value on all of our bud tenders and employees. Over the years we
have built a dedicated team of employees. We make sure they receive
the most up to date product training, and have considerable
knowledge of cannabis and CBD products.
Engagement with Our Community
At CLS Holdings, we are constantly looking at how we can
optimize our brands and provide a better service to our customers.
By conducting our business in that manner, we believe we can bring
value to our shareholders, a group that we proudly include
ourselves in. We are also extremely cognizant of the community in
which we do business and feel a real obligation to bring about
tangible positive change. In fact, the reason
I got into this business was to help a family member who was
in need of alternative pain relief, which we discovered
in medical cannabis - so it goes without saying that we are
serious in our mission to find ways that we can help others as we
build this business. For these reasons we have created and
financially support "Community Oasis", which sponsors events in our
space that celebrate lifestyle and cannabis, and we will be
designing a calendar of free events including yoga, creative
writing, painting, and drawing classes.
Planned Acquisition of In Good Health Business and
Mission to Become a Multi-State-Operator (MSO)
With the help of our dedicated staff and employees, as well as
our large contingent of loyal customers in the Las Vegas area we
have built a solid base to grow our business. Our
primary goal now is to take what we have learned in Nevada into new
states so that we can grow the CLS brand.
We look forward with much anticipation towards completing our
planned acquisition of the In Good Health integrated cannabis
business in the State of Massachusetts. Our goal is to complete
this acquisition in early 2020, subject to our receipt of
financing. The In Good Health business is extremely well aligned
with our existing business culture and its ownership group has done
a fantastic job of building one of the largest and most successful
medical cannabis businesses in the State (currently servicing
18,000 registered patients and delivering to 1,700 homes with key
product offerings of flower, concentrates, vapes, edibles,
pre-rolls and tinctures) and they anticipate opening for
recreational cannabis sales in the very near
future. Assuming we close on this acquisition as
planned, we see many synergies between the two operations that we
will utilize to grow our overall business and shareholder
value. We look forward to sharing these initiatives with
you once completed.
Excellent customer service. Premium quality products.
Proprietary cannabidiol extraction processes. Exceptional
employees. These are the core values that comprise our business
culture here at CLS Holdings. These principles are essential to our
mission to become the most reputable and profitable cannabis
company in the Country. We look forward to another successful year
in Fiscal 2020 as we continue to build the CLS Brand, and we look
forward to sharing these results with our valued shareholders at
the next quarterly update. Until then we wish you good health and
good fortune."
Forward Looking Statements
This press release contains certain ''forward-looking
information'' within the meaning of applicable Canadian securities
legislation and ''forward-looking statements'' as that term is
defined in the Private Securities Litigation Reform Act of 1995
(collectively, the ''forward-looking statements''). These
statements relate to anticipated future events, future results of
operations or future financial performance, and anticipated growth,
including the timing of anticipated construction and implementation
of our expansion plan. These forward-looking statements
also include statements relating to whether and when certain
transactions will be completed, including the proposed In Good
Health acquisition. In some cases, you can identify
forward-looking statements by terminology such as "may," "might,"
"will," "should," "intends," "expects," "plans," "goals,"
"projects," "anticipates," "believes," "estimates," "predicts,"
"potential," or "continue" or the negative of these terms or other
comparable terminology. These forward-looking statements are only
predictions, are uncertain and involve substantial known and
unknown risks, uncertainties and other factors which may cause our
actual results, levels of activity or performance to be materially
different from any future results, levels of activity or
performance expressed or implied by these forward-looking
statements, including, but not limited to, the risk that we may be
unable to secure financing for the acquisition of In Good Health
and the risk of regulatory issues or delays associated with our
expansion plan. We cannot guarantee future results, levels of
activity or performance and we cannot guaranty that the proposed
transactions described in this press release will occur. You should
not place undue reliance on these forward-looking statements, which
speak only as of the date that they were made. These cautionary
statements should be considered together with any written or oral
forward-looking statements that we may issue in the future. Except
as required by applicable law, we do not intend to update any of
the forward-looking statements to conform these statements to
reflect actual results, later events or circumstances or to reflect
the occurrence of unanticipated events. See CLS Holdings USA
filings with the SEC and on its SEDAR profile at www.sedar.com
for additional details.
Contact Information
Corporate:
Chairman and CEO
Jeff Binder
jeff@clsholdingsinc.com
888-438-9132
Investor Relations:
Torrey Hills Capital
Clay Chase
cc@sdthc.com
858-456-7300
CLS Holdings USA (CSE:CLSH.U)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
CLS Holdings USA (CSE:CLSH.U)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024